TMC Life Sciences Berhad announced earnings results for the third quarter ended May 31, 2020. For the third quarter, the company announced sales was MYR 34.873 million. Net loss was MYR 4.301 million. Basic loss per share from continuing operations was MYR 0.0025. For the nine months, sales was MYR 138.301 million. Net income was MYR 10.475 million. Basic earnings per share from continuing operations was MYR 0.006.